This inventor holds 2 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 2003-2006.
Company Filing History:
Years Active: 2003-2006
Title: David A Rubin: Innovator in Parathyroid Hormone Receptors
Introduction
David A Rubin is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of biochemistry, particularly in the study of parathyroid hormone receptors. With a total of 2 patents, his work has implications for both diagnostic and therapeutic methods.
Latest Patents
Rubin's latest patents focus on novel parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) receptors, specifically PTH1R and PTH3R, which have been isolated from zebrafish. These receptors share homology with previously identified PTH/PTHrP receptors. His patents provide isolated nucleic acid molecules encoding the zebrafish PTH1R and PTH3R receptors, as well as receptor polypeptides. Additionally, the patents include vectors, host cells, and recombinant methods for producing these receptors. The inventions also relate to screening methods for identifying agonists and antagonists of PTH1R and PTH3R receptor activity.
Career Highlights
David A Rubin is associated with The General Hospital Corporation, where he continues to advance research in his field. His work has been instrumental in enhancing the understanding of parathyroid hormone receptors and their potential applications.
Collaborations
Rubin has collaborated with notable colleagues, including Harald Jüppner, further enriching his research endeavors.
Conclusion
David A Rubin's innovative work in the field of parathyroid hormone receptors showcases his commitment to advancing medical science. His contributions have the potential to lead to significant advancements in diagnostic and therapeutic methods.